KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Treasury Shares: 2020-2024

Historic Treasury Shares for Castle Biosciences (CSTL) over the last 3 years, with Dec 2024 value amounting to $3.2 million.

  • Castle Biosciences' Treasury Shares was N/A to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year change of. This contributed to the annual value of $3.2 million for FY2024, which is N/A change from last year.
  • As of FY2024, Castle Biosciences' Treasury Shares stood at $3.2 million, which was up 204.35% from $1.1 million recorded in FY2021.
  • In the past 5 years, Castle Biosciences' Treasury Shares registered a high of $3.2 million during FY2024, and its lowest value of $161,477 during FY2020.
  • In the last 1 years, Castle Biosciences' Treasury Shares had a median value of $3.2 million in 2024 and averaged $3.2 million.
  • Data for Castle Biosciences' Treasury Shares shows a peak YoY spiked of 550.36% (in 2021) over the last 5 years.
  • Over the past 3 years, Castle Biosciences' Treasury Shares (Yearly) stood at $161,477 in 2020, then soared by 550.36% to $1.1 million in 2021, then reached $3.2 million in 2024.